WAIKOLOA, Hawaii — In this Healio Video Perspective from Retina 2022, Cedric Francois, MD, PhD, CEO of Apellis Pharmaceuticals, offers an update on the company’s lead drug candidate, pegcetacoplan, for the treatment of geographic atrophy.
Uncategorized
VIDEO: Apellis outlines 2022 regulatory plans for geographic atrophy candidate